Detecting and managing patients with type 2 diabetic kidney disease: Proteinuria and cardiovascular disease

WILLIAM E MITCH; SHAHNAZ SHAHINFAR; TANIA Z DICKSON; DICK DE ZEEUW; ZHONGXIN ZHANG

首页> 外文期刊>Kidney international. >Detecting and managing patients with type 2 diabetic kidney disease: Proteinuria and cardiovascular disease

【24h】

Detecting and managing patients with type 2 diabetic kidney disease: Proteinuria and cardiovascular disease

机译：检测和管理2型糖尿病肾病患者：蛋白尿和心血管疾病

获取原文

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Detecting and managing patients with type 2 diabetic kidney disease: Proteinuria and cardiovascular disease.BackgroundThe increasing prevalence of type 2 diabetes (T2DM) places more patients at risk for developing chronic kidney disease (CKD) or cardiovascular (CV) events. Effective therapy for CKD or CV disease (CVD) requires a method of identifying affected patients and monitoring the effectiveness of therapy.

机译：检测和管理2型糖尿病肾病：蛋白尿和心血管疾病。背景2型糖尿病（T2DM）患病率的上升使更多患者处于发展慢性肾脏病（CKD）或心血管（CV）事件的风险中。对CKD或CV疾病（CVD）的有效治疗需要一种识别受影响患者并监测治疗效果的方法。

著录项

来源
《Kidney international.》 |2004年第s92期|共2页
作者
WILLIAM E MITCH; SHAHNAZ SHAHINFAR; TANIA Z DICKSON; DICK DE ZEEUW; ZHONGXIN ZHANG;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类泌尿科学（泌尿生殖系疾病）;
关键词

相似文献

外文文献
中文文献
专利

1. Effects of Tangshen Formula on urinary and plasma liver-type fatty acid binding protein levels in patients with type 2 diabetic kidney disease: post-hoc findings from a multi-center, randomized, double-blind, placebo-controlled trial investigating the efficacy and safety of Tangshen Formula in patients with type 2 diabetic kidney disease [J] . Xin Yang, Bingxuan Zhang, Xiaoguang Lu, BMC Complementary and Alternative Medicine . 2016,第1期

机译：糖肾方对2型糖尿病肾病患者尿和血浆肝型脂肪酸结合蛋白水平的影响：一项多中心，随机，双盲，安慰剂对照试验的事后发现，旨在研究疗效和安全性肾方对2型糖尿病肾病的治疗作用
2. The role of glycated hemoglobin (HbA1c) and serum lipid profile measurements to detect cardiovascular diseases in type 2 diabetic patients [J] . Muhammad Naeem, Rehman Mehmood Khattak, Mati ur Rehman, South East Asia Journal of Public Health . 2015,第2期

机译：糖化血红蛋白（HbA1c）和血脂谱检测在2型糖尿病患者中检测心血管疾病的作用
3. The functional -374 T/A RAGE gene polymorphism is associated with proteinuria and cardiovascular disease in type 1 diabetic patients. [J] . Pettersson Fernholm K, Forsblom C, Hudson BI, Diabetes . 2003,第3期

机译：功能性-374 T / A RAGE基因多态性与1型糖尿病患者的蛋白尿和心血管疾病有关。
4. The impact of diabetic HbA1c exam on the occurrence of chronic kidney disease in type 2 diabetic patients [C] . Pi-I Li, Chih-Ching Chang Annual conference of the International Society of Exposure Science . 2014

机译：糖尿病HbA1c检查对2型糖尿病患者慢性肾脏疾病发生的影响
5. Annual Out-Of-Pocket Costs and Productivity Loss Among Patients with Diabetic Kidney Disease Compared to Type 2 Diabetes Mellitus [D] . ?Cha, Ashley Soojin 2020

机译：与2型糖尿病相比，糖尿病肾脏疾病患者的年度超港元和生产力丧失
6. Effects of Tangshen Formula on urinary and plasma liver-type fatty acid binding protein levels in patients with type 2 diabetic kidney disease: post-hoc findings from a multi-center randomized double-blind placebo-controlled trial investigating the efficacy and safety of Tangshen Formula in patients with type 2 diabetic kidney disease [O] . Xin Yang, Bingxuan Zhang, Xiaoguang Lu, 2016

机译：糖肾方对2型糖尿病肾病患者尿和血浆肝型脂肪酸结合蛋白水平的影响：一项多中心随机双盲安慰剂对照试验的事后发现旨在研究疗效和安全性肾方对2型糖尿病肾病患者的作用
7. Detecting and managing patients with type 2 diabetic kidney disease: Proteinuria and cardiovascular disease [O] . Mitch William E., Shahinfar Shahnaz, Dickson Tania Z., 2004

机译：检测和管理2型糖尿病肾病患者：蛋白尿和心血管疾病

Detecting and managing patients with type 2 diabetic kidney disease: Proteinuria and cardiovascular disease

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅